Company Viva Biotech Holdings

1873

KYG9390W1015

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:06 30/04/2024 pm IST			5-day change	1st Jan Change
0.53 ^HKD	-5.36%		+24.71%	-49.52%

28/03	Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023	CI
18/01	Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director	CI

VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Companyâs core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.

Number of employees: 2,077

Managers	Title	Age	Since
Ying Wu FOU	Founder	60	27/08/27
Chen Mao CEO	Chief Executive Officer	61	27/08/27
Wei Xiong DFI	Director of Finance/CFO	41	01/12
Zhe Ren Wang DFI	Director of Finance/CFO	40	01/21/01
Xue Heng Cheng CTO	Chief Tech/Sci/R&D Officer	69	23/19/23
Zhi Xiong Ye CTO	Chief Tech/Sci/R&D Officer	63	10/18/10
Delin Ren BRD	Director/Board Member	63	03/18/03
Xiaoyu Fei SEC	Corporate Secretary	36	10/18/10
Rongqiang Liu PRN	Corporate Officer/Principal	58	10/18/10
Hing Ling Chau SEC	Corporate Secretary	49	10/18/10

Members of the board	Title	Age	Since
Xiang Rong Li BRD	Director/Board Member	51	01/18/01
Hui Wang		-	-
Hai Guang Wang BRD	Director/Board Member	60	01/18/01
Hui Wang BRD	Director/Board Member	52	18/01
Yuting Wu BRD	Director/Board Member	53	14/22/14
Chen Mao CEO	Chief Executive Officer	61	27/08/27
Ying Wu FOU	Founder	60	27/08/27
Delin Ren BRD	Director/Board Member	63	03/18/03
Lei Fu BRD	Director/Board Member	61	01/18/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,945,966,305	1,233,028,657 ( 63.36 %)	19,600,000 ( 1.007 %)	63.36 %

Name	Equities	%	Valuation
Chen Mao 21.15 %	457,043,527	21.15 %	32 M $
Jiong Wu 10.13 %	219,034,092	10.13 %	15 M $
Jun Mao 6.064 %	131,057,654	6.064 %	9 M $
Ying Wu 0.9967 %	21,542,127	0.9967 %	1 M $
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.4627 %	10,000,000	0.4627 %	690 000 $
Bosera Asset Management Co., Ltd. 0.3840 %	8,299,500	0.3840 %	572 666 $
GF Fund Management Co., Ltd. 0.2390 %	5,165,000	0.2390 %	356 385 $
Dimensional Fund Advisors Ltd. 0.0430 %	928,753	0.0430 %	64 084 $
PMG Investment Solutions AG 0.0224 %	485,000	0.0224 %	33 465 $
Guotai Asset Management Co., Ltd. 0.0195 %	421,000	0.0195 %	29 049 $

Viva Biotech Holdings

No.735, Ziping Road

201318, Shanghai

+86 21 6089 3288

http://www.vivabiotech.com

Name	Category and Sector
Viva Incubator Investment Management Ltd. Viva Incubator Investment Management Ltd. Investment ManagersFinance Viva Incubator Investment Management Ltd. provides investment management services. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Chen Mao.	Investment Managers
Viva Biotech Investment Management Ltd. Viva Biotech Investment Management Ltd. Investment ManagersFinance Viva Biotech Investment Management Ltd. provides investment management services. The private company is based in Road Town, British Virgin Islands.	Investment Managers

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
VIVA BIOTECH HOLDINGS	-49.52%	145M
ELI LILLY AND COMPANY	+31.99%	704B
NOVO NORDISK A/S	+28.33%	577B
JOHNSON & JOHNSON	-4.94%	348B
MERCK & CO., INC.	+17.63%	327B
ABBVIE INC.	+4.18%	288B
ASTRAZENECA PLC	+14.79%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-4.89%	147B

Other Pharmaceuticals